Keywords:
иммунная тромбоцитопеническая пурпура, тромбоцит, тромбопоэтины.References
Ковалева Л.Г., Пустовая Е.И., Сафонова Т.И. Идиопатическаятромбоцитопеническая пурпура (ИТП) взрослых. Первичная иммунная тромбоцитопения (ИТП) взрослых. Болезнь Верльгофа. М.: Нью Мун; 2014.
Ковалева Л.Г., Сафонова Т.И., Пустовая Е.И., Колосова Е.Н., Рядненко А.А. Клинико-статистические данные и оценка различных методов терапии идиопатической тромбоцитопенической пурпуры. Терапевтический архив. 2011; 4: 60--5.
Лисуков И.А., Масчан А.А., Шамардина А.В., Чагорова Т.В., Давыдкин И.Л., Сычева Т.М. и др. Иммунная тромбоцитопения: клинические проявления и ответ на терапию. Промежуточный анализ данных Российского регистра пациентов с первичной иммунной тробоцитопенией и обзор литературы. Онкогематология. 2013; 2:61-9.
Масчан А.А., Румянцев А.Г., Ковалева Л.Г., Афанасьев Б.В., Поспелова Т.И., Зарицкий А.Ю. и др. Рекомендации Российского совета экспертов по диагностике и лечению больных первичной иммунной тробоцитопенией. Онкогематология. 2010; 3: 36-45.
Melikyan A.L., Pustovaya E.I., Volodicheva E.M., Kolosheinova T.I., Kalinina M.V., Zotina E.N., et al. Incidence of Primary Immune Thrombocytopenia (ITP) in adults in one region of Russia. Blood. 2016;
Brighton TA, Evans S, Castaldi PA, et al. Prospective evaluation of the clinical usefulness of an antigen–specific assay (MAIPA) in idiopathic throm-bocytopenic purpura and other immune thrombocy-topenias. Blood. 1996;88:194–201.
British Committee for Standards in Haematology General Haematology Task Force.Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br. J. Haematol. 2003; 120(4): 574--96
Bussel JB, Kuter DJ, George JN, et al. AMG 531, a thrombopoiesis–stimulating protein, for chronic ITP. N Engl J Med 2006;355:1672–81. [Erratum, N Engl J Med 2006;355:2054.].9. Clines D.B., Bussel J.B. How I treat ITP. Blood. 2005; 106(7): 2244--51.
Fogarty P. Chronic ITP in adults: epidemi-ology and clinical presentation. Hematol. Oncol. Clin. North. Am. 2009; 23(6): 1213--21. doi: 10.1016/ j.hoc.2009.08.004.
Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood. 1999;94:909–13.
Geddis AE, Linden HM, Kaushansky K. Thrombopoietin: a panhematopoietic cytokine. Cytokine Growth Factor Rev 2002;13:61–73.
George JN, El–Harake MA, Aster RH. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In Williams Hematology, ed. E Beutler, MA Lichtman, BS Coller, TJ Kipps, 1995; pp. 1315–55. New York: McGraw–Hill.14. Gernsheimer T., McCrae K.R. Immune throm-bocytopenic purpura in pregnancy. Curr.Opin. Hematol. 2007; 14(5): 574--80
Kuter DJ, Begley CG. Recombinant. human thrombopoietin: basic biology and evaluation of clinical studies. Blood 2002;100:3457–69.
McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann. Intern. Med. 1997;126:307–14.
Neunert C., Lim W., Crowther M., Cohen A., Solberg L.Jr., Crowther M.A. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011; 117(16): 4190--207. doi: 10.1182/blood-2010-08-302984.
Newland A, Caulier MT, Kappers–Klune M, et al. An openlabel, unit dosefinding study of AMG 531 a novel, thrombopoiesis stimulating peptibody, in patients with immune thrombocytopenic purpura. Br J. Haematol 2006;135:547–53.
Provan D., Stasi R., Newland A.S., Blanchette V.S., Bolton-Maggs P., Bussel J.B., et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010; 115(2): 168--86. doi: 10.1182/blood-2009-06-225565.
Rodeghiero F., Stasi R., Gernsheimer T., Michel M., Provan D., Arnold D.M., et al.Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from international working group. Blood. 2009; 113(11): 2386--93. doi: 10.1182/blood -2008-07-162503.
Vainchenker W, Debili N, Methia N, Mouthon MA, Wendling F. Hematopoiesis and its regulation: comparison between erythropoiesis and megakaryocytopenias. Bull Acad Natl Med 1994; 178:753–78. 22. von dem Borne A, Folman C, van den Oudenrijn S, Linthorst G, de Jong S, de Haas M. The potential role of thrombopoietin in idiopathic thrombocytopenic purpura. Blood Rev 2002;16:57–9. 23. Webert K.E., Mittal R., Sigouin C., Heddle N.M., Kelton J.G. A retrospective, 11-year analysis of obstetrical patients with idiopathic thrombocytopenic purpura. Blood. 2003; 102(13): 4306--11.
Zitek T, Weber L, Pinzon D, Warren N. Assessment and Management of Immune Thrombocy-topenia (ITP) in the Emergency Department: Current Perspectives. Open Access Emerg Med. 2022;14:25-34.